Amylyx Pharmaceuticals (AMLX) Stock Chart & Stock Price History $5.44 -0.08 (-1.45%) Closing price 04:00 PM EasternExtended Trading$5.64 +0.20 (+3.75%) As of 04:49 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Amylyx Pharmaceuticals Stock Price Performance The Amylyx Pharmaceuticals (AMLX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 231.71%, with a year-to-date return of 43.92%. In the past month, the stock has increased 12.40%, reflecting recent market activity. As of the latest close, Amylyx Pharmaceuticals traded at $5.52 with a market cap of $492.06 million and volume of 890,299 shares. Receive AMLX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Amylyx Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+0.37%1 Month Performance+12.40%3 Month Performance+49.86%Year-To-Date Performance+43.92%1 Year Performance+231.71% AMLX Stock Chart for Monday, June, 16, 2025 AMLX Chart by TradingView Amylyx Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/13/2025$5.52$5.52$5.55$5.33890,299 shs$492.06 million06/12/2025$5.42$5.52+1.85%$5.58$5.241.04 million shs$492.06 million06/11/2025$5.76$5.42-5.90%$6.08$5.38859,850 shs$483.14 million06/10/2025$5.44$5.76+5.88%$5.90$5.431.39 million shs$513.45 million06/09/2025$5.33$5.44+2.06%$5.48$5.24588,871 shs$484.93 million06/06/2025$5.05$5.33+5.54%$5.34$4.99757,278 shs$475.12 million06/05/2025$4.92$5.05+2.64%$5.07$4.76693,014 shs$450.16 million06/04/2025$5.12$4.92-3.91%$5.12$4.90536,561 shs$438.57 million06/03/2025$5.10$5.12+0.39%$5.32$4.981.01 million shs$456.40 million06/02/2025$5.23$5.10-2.49%$5.20$4.84795,928 shs$454.62 million Get the Latest News and Ratings for AMLX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Amylyx Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 05/30/2025$4.90$5.23+6.73%$5.33$4.711.37 million shs$466.21 million05/29/2025$4.79$4.90+2.30%$4.92$4.71550,620 shs$436.79 million05/28/2025$4.72$4.79+1.48%$4.83$4.64498,233 shs$426.99 million05/27/2025$5.31$4.72-11.11%$5.40$4.691.02 million shs$420.75 million05/26/2025$5.31$5.31$5.38$5.09906,493 shs$473.34 million05/23/2025$5.36$5.31-0.93%$5.38$5.09906,493 shs$473.34 million05/22/2025$5.43$5.36-1.29%$5.50$5.25916,784 shs$477.80 million05/21/2025$5.52$5.43-1.63%$5.55$5.19755,558 shs$484.04 million05/20/2025$5.36$5.52+2.99%$5.54$5.221.58 million shs$492.06 million05/19/2025$4.84$5.36+10.74%$5.48$4.712.00 million shs$477.80 million05/16/2025$4.52$4.84+7.08%$4.86$4.47798,017 shs$431.44 million05/15/2025$4.35$4.52+3.91%$4.54$4.27446,268 shs$402.66 million Related Companies IDEAYA Biosciences Stock Chart Schrödinger Stock Chart Indivior Stock Chart Galapagos Stock Chart Apogee Therapeutics Stock Chart Beam Therapeutics Stock Chart Immunocore Stock Chart Tarsus Pharmaceuticals Stock Chart Bausch Health Companies Stock Chart Disc Medicine Stock Chart Receive AMLX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Amylyx Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:AMLX) was last updated on 6/16/2025 by MarketBeat.com Staff From Our PartnersAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredWhen This Happens, You Don’t Wait. You Act.This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredSomething Big Is Coming...Man who predicted Lehman Crash Warns "Get OUT of Cash" He predicted the 2008 crisis and recommended shortin...Stansberry Research | SponsoredBREAKING: Trump vs. Elon Feud Threatens Your Retirement – Protect Yourself NOW"This isn't just a war of words. This is a financial time bomb. The escalating battle between Donald Trump a...American Alternative | SponsoredThe mainstream media is wrong about AI — againThe mainstream media got it wrong … yet again. Chinese AI chatbot DeepSeek turned the tech world on its hea...Weiss Ratings | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe one deadline Elon can't afford to miss...For years, Elon Musk made headlines for blowing past deadlines — so often that investors coined a nickname for...Brownstone Research | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Amylyx Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Amylyx Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
